ras p21 immunostaining in early stage squamous cervical carcinoma: Relationship with lymph nodal involvement and 72 kDa-metalloproteinase index

Anticancer Research

Volumn 18, Issue 1 B, 1998, Pages 609-613

  Garzetti, G Gioele ^a   Ciavattini, Andrea ^a   Lucarini, Guendalina ^a   Goteri, Gaia ^a   De Nictolis, Michele ^a   Romanini, Carlo ^a   Biagini, Graziella ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

72 kDa metalloproteinase; Cervical carcinoma; Collagenase; Lymphatic spread; Metalloproteinase; Metastatization; Nodal involvement; Oncogenes; Prognosis; ras p21

Indexed keywords

AVIDIN; BIOTIN; ENZYME ANTIBODY; METALLOPROTEINASE; MONOCLONAL ANTIBODY; RAS PROTEIN;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER STAGING; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION; TUMOR VOLUME; UTERINE CERVIX CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; METALLOENDOPEPTIDASES; MIDDLE AGED; ONCOGENE PROTEIN P21(RAS); RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 0031900232     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Land HG, Parada G, Weinberg R: Cellular oncogenes and multistep carcinogenesis. Science 222: 771, 1984.
2. Fromowitz FB, Viola MV, Chao S, Oravez S, ishriki Y, Finkel G, Grimson R, Lundy J: ras p21 expression in the progression of breast cancer. Hum Pathol 18: 1268-75, 1984
3. Hayashi Y, Hachisuga T, Iwasaka T, Fukuda K, Okuma Y, Yokoyama M, Sugimori H: Expression of ras oncogene product and EGF receptor in cervical squamous cell carcinomas and its relationship to lymph node involvement. Gynecol Oncol 40: 147-151,1991
4. Sagae S, Kuzumaki N, Hisada T, Mugikura Y, Kudo R, Hashimoto M: ras oncogene expression and prognosis of invasive squamous cell carcinomas of the uterine cervix. Cancer 63: 1577-82, 1989
5. Sagae S, Kudo R, Kuzumaki N, Hisada T, Mugikura Y, Nihei T, Takeda T, Hashimoto M: Ras oncogene expression and progression in intraepithelial neoplasia of the uterine cervix. Cancer 66: 295-301, 1990.
6. King LA, Okagaki T, Gallup DG, Twiggs LB, Messing MJ, Carson LF: Mitotic count, nuclear atypia, and immunohistochemical detemmination of Ki67, c-myc, p21-ras, c-erbB2, and p53 expression in granulosa cell tumors of the ovary: mitotic count and Ki67 are indicator of poor prognosis. Gynecol Oncol 61: 227-232, 1996.
7. Lundy J, Grimson R, Mishriki Y, et al: Elevated ras oncogene expression correlates with lymph node metastasis in breast cancer patients. J Clin Oncol 14: 1321, 1986.
8. Nakajima M, Welch D, Belloni PN, Nicolson GL: Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials. Cancer Res 47: 4869-4876, 1987.
9. Nakajima M, Lotan D, Baig MM, Carralero RM, Wood WR, Hendrix MJC: Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells. Cancer Res 49: 1698-706, 1989.
10. Martinez-Hemandez A, Amenta PS: The basement membrane in pathology. Lab Invest 48: 656-677, 1983.
11. Garzetti GG, Ciavattini A, Lucarini G, Goteri G, De Nictolis M, Garbisa S, Masiero L, Romanini C, Biagini G: Tissue and serum metalloproteinase (MMP-2) expression in advanced ovarian serous cystoadenocarcinomas: clinical and prognostic implications. Anticancer Res 75: 2799-2804, 1995.
12. Garzetti GG, Ciavattini A, Lucarini G, Goteri G, Romanini C, Biagini G: The 72 kDa metalloproteinase immunostaining in cervical carcinoma: relationship with lymph nodal involvement. Gynecol Oncol 60: 271-276, 1996.
13. Garzetti GG; Ciavattini A, Lucarini G, Goteri G, De Nictolis M, Romanini C, Biagini G: Recurrence pattems in locally advanced cervical carcinoma: role of nodal status and 72 kDa metalloproteinase. Gynecol Oncol 61: 83-89, 1996.
14. Piver MS, Rutledge F, Smith JP: Five classes of extended hysterectomy for women with cervical cancer, Obstet. Gynecol 44: 265-272, 1974.
15. Hsu SM, Raine L, Fanger H: The use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase tecnique: a comparison between ABC and unlabeled antibody (PAP) procedures, J. Histochem. Cytochem 29: 577-581, 1981.
16. Hand PH, Thor A, Wunderlich D: Monoclonal antibodies with a predetermined specificity detect activated ras gene expression in human mammary and colon carcinomas. Proc Natl Acad Sci USA 81: 5227, 1984.
17. Gallick G, Kurzrock R, Kloetzer W: Expression of ras p21 in fresh primary and metastatic human colorectal tumors. Proc Natl Acad Sci 82: 1795, 1985.
18. Viola MV, Fromowitz F, Oravez S et al: ras oncogene p21 expression is increased in premalignant lesions and high grade bladder carcinomas. J Exp Med 161: 1213, 1985
19. Bondy GP, Wilson S, Chambers AF: Experimental metastatic ability of H-ras transformed NIH3T3 cells. Cancer Res 45: 6005, 1985
20. Thorgeirsson UP, Turpenniemi-Hujanen T, Williams JE, et al: NIH3T3 cells transfected with human tumor DNA containing activated ras oncogenes express the metastatic phenotype in nude mice. Mol Cell Biol 5: 259, 1985.
21. Lai CH, Chang HC, Chang TC, Hsueh S, Tang SG: Prognostic factors and impacts of adjuvant therapy in early-stage cervical carcinoma with pelvic node metastasis. Gynecol Oncol 51: 390-396, 1993.
22. Inoue T, Morita K: The prognostic significance of number of positive nodes in cervical canrcinoma stages IB, IIA, and IIB. Cancer 65: 1923-1927, 1990.
23. Coleman DL, Gallup DG, Wolcott HD, Otken LB, Stock RJ: Patterns of failure of bulky-barrel carcinomas of the cervix. Am J Obstet Gynecol 166: 916-920, 1992.
24. Sherman DD, Gonnering RS, Wallow IH, Lemke BN, Doos WG, Dortzbach RK, Lyon DB, Bindley CD: Ophthal Plast Reconst Surg 9: 153-169, 1993.
25. Kristein M, Sanz L, Qinones S, Moscat J, Diaz Meco MT, Saus J: Cross-talk between different enancher elements during mitogenic induction of the human stromelysin-1 gene. J Biol Chem 277; 18231-18236, 1996.